CDC Guideline for Prescribing Opioids for Chronic Pain--United States, 2016.

@article{Dowell2016CDCGF,
  title={CDC Guideline for Prescribing Opioids for Chronic Pain--United States, 2016.},
  author={Deborah Dowell and Tamara M. Haegerich and Roger Chou},
  journal={JAMA},
  year={2016},
  volume={315 15},
  pages={
          1624-45
        }
}
IMPORTANCE Primary care clinicians find managing chronic pain challenging. Evidence of long-term efficacy of opioids for chronic pain is limited. Opioid use is associated with serious risks, including opioid use disorder and overdose. OBJECTIVE To provide recommendations about opioid prescribing for primary care clinicians treating adult patients with chronic pain outside of active cancer treatment, palliative care, and end-of-life care. PROCESS The Centers for Disease Control and… 

CDC Guideline for Prescribing Opioids for Chronic Pain - United States, 2016.

This guideline is intended to improve communication between clinicians and patients about the risks and benefits of opioid therapy for chronic pain, improve the safety and effectiveness of pain treatment, and reduce the risks associated with long-term opioid therapy, including opioid use disorder, overdose, and death.

CDC Clinical Practice Guideline for Prescribing Opioids for Pain — United States, 2022

This clinical practice guideline is intended to improve communication between clinicians and patients about the benefits and risks of pain treatments, including opioid therapy, to improve the effectiveness and safety of pain treatment; mitigate pain; improve function and quality of life for patients with pain.

Responsible Prescribing of Opioids for Chronic Non-Cancer Pain: A Scoping Review

This review aimed to summarise controlled trials and systematic reviews that evaluate patient- related, provider-related, and system-related factors supporting responsible opioid prescribing for chronic non-cancer pain.

Opioid reduction for patients with chronic pain in primary care: systematic review

Results carefully point in the direction of a GP supervised tapering and multidisciplinary group therapeutic sessions to reduce long-term opioid treatment, but because of high risk of bias and small sample sizes, no firm conclusions can be made demonstrating the need for more high-quality research.

Prescribing Opioids for Chronic Pain.

The Centers for Disease Control and Prevention guideline for prescribing opioids for chronic pain is a welcome correction of opioid-prescribing practices that stemmed from inadequate evidence and flawed reviews, but the review by Dr Dowell and colleagues also had shortcomings.

Prescribing Opioids for Chronic Pain.

The Centers for Disease Control and Prevention guideline for prescribing opioids for chronic pain is a welcome correction of opioid-prescribing practices that stemmed from inadequate evidence and flawed reviews, but the review by Dr Dowell and colleagues also had shortcomings.

Reducing Opioid Use for Patients With Chronic Pain: An Evidence‐Based Perspective

&NA; The implementation of recent Centers for Disease Control and Prevention recommendations to move away from opioids and toward nonpharmacological therapies for the treatment of chronic pain could

Alternatives to Opioids in the Pharmacologic Management of Chronic Pain Syndromes: A Narrative Review of Randomized, Controlled, and Blinded Clinical Trials

While many nonopioid analgesics have been found to be effective in reducing pain for many chronic pain conditions, it is evident that the number of high-quality studies is lacking, and the effect sizes noted in many studies are not considered to be clinically significant despite statistical significance.

Evidence-Based Strategies for Treatment and Referral of Chronic Pain in Primary Care

This paper will address evidence-based strategies for PCPs to aid them in appropriate referral processes and provide guidelines for safe and effective prescription of opioid medication for patients with chronic pain.

The Potential Impact on Children of the CDC Guideline for Prescribing Opioids for Chronic Pain: Above All, Do No Harm.

This document is intended to offer recommendations for prescribing opioids for chronic pain outside of active cancer, palliative, and end-of-life care and is concerned that because this guideline is written for primary care clinicians, family physicians and pediatricians will assumethat they can be extrapolated downward to thepediatric population for whom it was not intended.
...

References

SHOWING 1-10 OF 320 REFERENCES

CDC Guideline for Prescribing Opioids for Chronic Pain - United States, 2016.

This guideline is intended to improve communication between clinicians and patients about the risks and benefits of opioid therapy for chronic pain, improve the safety and effectiveness of pain treatment, and reduce the risks associated with long-term opioid therapy, including opioid use disorder, overdose, and death.

The Effectiveness and Risks of Long-Term Opioid Treatment of Chronic Pain.

Evidence on long-term opioid therapy for chronic pain is very limited but suggests an increased risk of serious harms that appears to be dose-dependent, with several studies showing a dose- dependent association.

American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: Part 2--guidance.

A robust agreement which is followed by all parties is essential in initiating and maintaining opioid therapy as such agreements reduce overuse, misuse, abuse, and diversion.

ACOEM practice guidelines: opioids for treatment of acute, subacute, chronic, and postoperative pain.

The American College of Occupational and Environmental Medicine's guidelines have been updated to develop more detailed guidance for treatment of acute, subacute, chronic, and postoperative pain with opioids, with a recommended morphine equivalent dose limit of no more than 50 mg/day.

A randomized trial of 2 prescription strategies for opioid treatment of chronic nonmalignant pain.

Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain.

Opioids Compared With Placebo or Other Treatments for Chronic Low Back Pain: An Update of the Cochrane Review

There is evidence of short-term efficacy (moderate for pain and small for function) of opioids to treat CLBP compared with placebo, and the effectiveness and safety of long-term opioid therapy for treatment of CLBP remains unproven.

The Effectiveness and Risks of Long-Term Opioid Therapy for Chronic Pain: A Systematic Review for a National Institutes of Health Pathways to Prevention Workshop

This review focuses on adults with chronic pain and addresses the following key questions: what is the effectiveness of long-term opioid therapy versus placebo, no opioid therapy, or nonopioid therapy for long- term (>1 year) outcomes related to pain, function, and quality of life; and risk for overdose, addiction, abuse, or misuse.

Attitudes toward the Canadian Guideline for Safe and Effective Use of Opioids for Chronic Non-Cancer Pain: A qualitative study.

The attitudes toward, and use of, the Canadian Opioids Guideline among pain physicians are investigated and it is found that the guideline is excessively long and the format suboptimal, and improved dissemination and education are needed to enhance guideline uptake.
...